⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JNJ News
Johnson & Johnson
Acute Myocardial Infarction (AMI) - Market Insights, Epidemiology, and Market Forecast Now Available; Acute Myocardial Infarction (AMI) Market Projected to Reach Approximately USD 6.00 Billion by 2036
globenewswire.com
AMGN
MRK
REGN
AZN
PFE
BMY
JNJ
VTRS
CELC
NVO
ARWR
Global Surgical Robots Market Size, Share, Growth, and Forecast 2026-2034 by Component, Surgery, Country, and Company | AI Adoption Fuels a 9.13% CAGR to US$ 15.89 Billion
globenewswire.com
ISRG
SYK
JNJ
SNN
ZBH
Global Precision Medicine Market Size, Share, Growth, and Forecast 2026-2035 | AI, Genomics, and Targeted Therapies Drive 11.10% CAGR Toward USD 468.56 Billion by 2035
globenewswire.com
PFE
JNJ
AMGN
ILMN
BMY
DHR
BIIB
Global Point-of-Care (POC) Diagnostics Market Size, Share, Growth, and Forecast 2026-2035 | Decentralized and Home Testing Drive 8.5% CAGR Toward USD 36.92 Billion
globenewswire.com
ABT
JNJ
DHR
BDX
Pharmaceutical Manufacturing Market Size, Share, Trends, and Forecast, 2026-2033 | Biologics and Automation Drive 5.88% CAGR and USD 990.55 Billion Opportunity
globenewswire.com
PFE
JNJ
MRK
LLY
ABBV
TMO
Japan Cell and Gene Therapy Manufacturing Market Forecast to 2035 | Market to Reach USD 5.15 Billion at 29.0% CAGR as Commercial-Scale Capacity and Gene Therapies Expand
globenewswire.com
TMO
CAT
CRL
AMGN
BMY
GILD
AZN
NVS
MRK
JNJ
LLY
ABBV
Global Orphan Drugs Market Size, Share, Trends, and Forecast 2026-2034 | Market to Reach USD 589.2 Billion as Genomics, Precision Medicine, and Regulatory Incentives Drive Growth
globenewswire.com
AMGN
AZN
GNE
GSK
JNJ
MRK
NVS
PFE
SNY
BMY
REGN
BIIB
GILD
ABBV
EXEL
CRSP
NTLA
EDIT
INCY
VRTX
Orphan Drugs - Global Market Size, Share, Industry Trends, and Growth Forecasts, 2025-2031 | Biologics and Asia-Pacific Drive 6.36% CAGR to USD 334.28 Billion
globenewswire.com
ABBV
AMGN
AZN
BMRN
BMY
CSL
GSK
JNJ
NVS
PFE
REGN
SNY
SRPT
VRTX
ViiV Healthcare’s long-acting HIV treatment Cabenuva (cabotegravir + rilpivirine) meets primary endpoint of superior viral suppression vs. daily oral therapy in people with viremia
businesswire.com
GSK
JNJ
Global Immunotherapy Drugs Market - Size, Share, Trends, Competitive Landscape, and Forecast - 2034 | Market to Reach USD 837.14 Billion as Cell Therapies Drive 13.05% CAGR
globenewswire.com
MRK
BMY
NVS
ROG
AMGN
IBIO
AZN
JNJ
GSK
IOVA
ABBV